Susquehanna International Group, LLP Aclaris Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 62,408 shares of ACRS stock, worth $180,983. This represents 0.0% of its overall portfolio holdings.

Number of Shares

62,408

Previous 206,600 69.79%

Holding current value

$180,983

Previous $227,000 69.16%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.12 - $1.4 $161,495 - $201,868	-144,192 Reduced 69.79%	62,408 $70,000
Q2 2024 Aug 15, 2024	BUY	$1.01 - $1.36 $83,971 - $113,070	83,140 Added 67.34%	206,600 $227,000
Q1 2024 May 07, 2024	SELL	$0.92 - $1.44 $27,737 - $43,414	-30,149 Reduced 19.63%	123,460 $153,000
Q4 2023 Feb 14, 2024	BUY	$0.64 - $6.49 $19,045 - $193,135	29,759 Added 24.03%	153,609 $161,000
Q3 2023 Nov 14, 2023	BUY	$6.56 - $10.95 $681,190 - $1.14 Million	103,840 Added 518.94%	123,850 $848,000
Q2 2023 Aug 11, 2023	SELL	$7.89 - $10.64 $66,796 - $90,078	-8,466 Reduced 29.73%	20,010 $207,000
Q1 2023 May 16, 2023	BUY	$7.07 - $17.95 $201,325 - $511,144	28,476 New	28,476 $230,000
Q3 2022 Nov 14, 2022	BUY	$13.07 - $18.22 $294,545 - $410,605	22,536 New	22,536 $355,000
Q1 2022 May 16, 2022	BUY	$9.74 - $17.92 $52,683 - $96,929	5,409 Added 22.83%	29,100 $502,000
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.49 $129,742 - $195,513	10,574 Added 80.61%	23,691 $344,000
Q3 2021 Nov 15, 2021	SELL	$13.38 - $18.8 $780,682 - $1.1 Million	-58,347 Reduced 81.65%	13,117 $236,000
Q2 2021 Aug 11, 2021	SELL	$17.08 - $29.6 $6.43 Million - $11.1 Million	-376,171 Reduced 84.04%	71,464 $1.26 Million
Q1 2021 May 17, 2021	BUY	$5.86 - $27.73 $1.98 Million - $9.35 Million	337,086 Added 304.92%	447,635 $11.3 Million
Q4 2020 Feb 16, 2021	BUY	$2.65 - $7.61 $292,954 - $841,277	110,549 New	110,549 $715,000
Q1 2020 May 15, 2020	SELL	$0.75 - $2.18 $22,981 - $66,799	-30,642 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.02 - $1.97 $2,200 - $4,249	2,157 Added 7.57%	30,642 $58,000
Q3 2019 Nov 14, 2019	SELL	$0.79 - $2.47 $33,502 - $104,747	-42,408 Reduced 59.82%	28,485 $31,000
Q2 2019 Aug 16, 2019	BUY	$2.13 - $7.06 $10,019 - $33,210	4,704 Added 7.11%	70,893 $155,000
Q2 2019 Aug 14, 2019	BUY	$2.13 - $7.06 $109,096 - $361,606	51,219 Added 342.14%	66,189 $145,000
Q1 2019 May 15, 2019	BUY	$5.63 - $7.84 $84,281 - $117,364	14,970 New	14,970 $90,000
Q3 2018 Nov 14, 2018	SELL	$14.38 - $20.89 $331,200 - $481,138	-23,032 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$16.46 - $20.33 $170,097 - $210,090	10,334 Added 81.38%	23,032 $460,000
Q1 2018 May 15, 2018	SELL	$17.08 - $25.64 $1.03 Million - $1.55 Million	-60,396 Reduced 82.63%	12,698 $222,000
Q4 2017 Feb 14, 2018	BUY	$21.47 - $27.8 $1.57 Million - $2.03 Million	73,094	73,094 $1.8 Million

Others Institutions Holding ACRS

# of Institutions

Shares Held

50.7M

Call Options Held

30.6K

Put Options Held

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $193M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Aclaris Therapeutics, Inc. Transaction History